Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

TCGX doubles down on China with $600M Asia-focused fund

Chen Yu's TCGX, a private and public biotech investment firm, is going to invest directly in life sciences companies in China and elsewhere in Asia. The Palo Alto, CA-based firm on Wednesday announced a $600 ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 7 October →